NanoViricides Holds 2024 Annual Meeting; Shareholder Proposals Approved ENDOTITLENanoViricides, Inc. recently convened its 2024 Annual Meeting of Stockholders on December 7, 2024. At the meeting, a substantial portion of the company’s voting stock wa

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read NanoViricides’s 8K filing here. NanoViricides Company Profile (Get Free Report) NanoViricides, Inc, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company’s product portfolio […]

Leave a Reply

Your email address will not be published.

Previous post 1ST Source Bank Sells 1,685 Shares of General Electric (NYSE:GE)
Next post Eli Lilly and Company (NYSE:LLY) Shares Sold by Franklin Resources Inc.